121 related articles for article (PubMed ID: 31519603)
1. Increased Risk of Breast and Uterine Cancer Among Women With Ovarian Granulosa Cell Tumors.
Nasioudis D; Wilson E; Mastroyannis SA; Sisti G; Haggerty AF; Ko EM; Latif NA
Anticancer Res; 2019 Sep; 39(9):4971-4975. PubMed ID: 31519603
[TBL] [Abstract][Full Text] [Related]
2. Other Primary Malignancies Among Women With Adult-Type Ovarian Granulosa Cell Tumors.
Bryk S; Pukkala E; Färkkilä A; Heikinheimo M; Unkila-Kallio L; Riska A
Int J Gynecol Cancer; 2018 Oct; 28(8):1529-1534. PubMed ID: 30036228
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
4. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
5. Ovarian granulosa cell tumor and increased risk of breast cancer.
Hammer A; Lauszus FF; Petersen AC
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1422-5. PubMed ID: 24283356
[TBL] [Abstract][Full Text] [Related]
6. Epithelial ovarian cancer and low malignant potential (LMP) tumors associated with a lower incidence of second primary breast cancer.
Hunter MI; Ziogas A; Flores F; Brewster WR
Am J Clin Oncol; 2007 Feb; 30(1):1-7. PubMed ID: 17278887
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of second primary malignancies in patients with gynecological cancer. A Swedish record-linkage study.
Bergfeldt K; Einhorn S; Rosendahl I; Hall P
Acta Oncol; 1995; 34(6):771-7. PubMed ID: 7576744
[TBL] [Abstract][Full Text] [Related]
8. Risk of Second Primary Tumors After Childhood and Adolescent Ovarian Malignancies: A SEER Analysis (1973-2011).
Nasioudis D; Ramer I; Sisti G; Fambrini M
J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):522-5. PubMed ID: 26152647
[TBL] [Abstract][Full Text] [Related]
9. Risk of contralateral breast cancer according to first breast cancer characteristics among women in the USA, 1992-2016.
Ramin C; Withrow DR; Davis Lynn BC; Gierach GL; Berrington de González A
Breast Cancer Res; 2021 Feb; 23(1):24. PubMed ID: 33596988
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma.
Werner-Wasik M; Schmid CH; Bornstein LE; Madoc-Jones H
Cancer; 1995 May; 75(9):2281-5. PubMed ID: 7712437
[TBL] [Abstract][Full Text] [Related]
11. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
12. Risk of Second Primary Female Genital Malignancies in Women with Breast Cancer: a SEER Analysis.
Li Z; Wu Q; Song J; Zhang Y; Zhu S; Sun S
Horm Cancer; 2018 Jun; 9(3):197-204. PubMed ID: 29556910
[TBL] [Abstract][Full Text] [Related]
13. Cervical cancer survivors at increased risk of subsequent tobacco-related malignancies, United States 1992-2008.
Underwood JM; Rim SH; Fairley TL; Tai E; Stewart SL
Cancer Causes Control; 2012 Jul; 23(7):1009-16. PubMed ID: 22588679
[TBL] [Abstract][Full Text] [Related]
14. Decreasing secondary primary uterine cancer after breast cancer: A population-based analysis.
Matsuo K; Mandelbaum RS; Machida H; Yoshihara K; Muggia FM; Roman LD; Wright JD
Gynecol Oncol; 2019 Jul; 154(1):169-176. PubMed ID: 31130286
[TBL] [Abstract][Full Text] [Related]
15. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of second cancer among patients with ovarian borderline tumors.
Bouchardy C; Fernandez S; Merglen A; Usel M; Fioretta G; Rapiti E; Schubert H; Pelte MF; Chappuis PO; Vlastos G
Gynecol Oncol; 2008 May; 109(2):210-4. PubMed ID: 18377966
[TBL] [Abstract][Full Text] [Related]
17. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
[TBL] [Abstract][Full Text] [Related]
18. The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden.
Sackey H; Hui M; Czene K; Verkooijen H; Edgren G; Frisell J; Hartman M
Breast Cancer Res; 2016 Oct; 18(1):105. PubMed ID: 27756431
[TBL] [Abstract][Full Text] [Related]
19. Risk of second malignant neoplasms in women and girls with germ cell tumors.
Liao Z; Rodrigues MC; Poynter JN; Amatruda JF; Rodriguez-Galindo C; Frazier AL
Ann Oncol; 2017 Feb; 28(2):329-332. PubMed ID: 27864217
[TBL] [Abstract][Full Text] [Related]
20. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
